Meat Prices Fall in February
The U.S. Department of Agriculture (USDA) released its preliminary report on February farm prices Monday afternoon.
The U.S. Department of Agriculture (USDA) released its preliminary report on February farm prices Monday afternoon.
The question that Urban Outfitters investors may be asking is whether the stock's recent momentum can continue.
24/7 Wall St. has not been overly concerned about Chevron's dividend -- we still see it hiking the dividend minimally.
News broke Monday that Teva Pharmaceutical Industries will acquire Auspex Pharmaceuticals. Existing investors will be wondering if they are getting enough in this buyout.
What does a visionary CEO like Elon Musk do when he sees that his shares of Tesla Motors are close to 52-week lows and down over 35% from their highs?
Boston Scientific shares are up almost 50% in the past six months, and the stock has more than doubled from two years ago. The question is whether this turnaround can keep turning around.
Chesapeake is between a rock and hard place. It needs to sell assets to help it reduce its debt, but it needs the assets to replace extracted reserves.
Analysts across the board are incredibly bullish on Skyworks Solutions, and the company is experiencing rapid earnings and revenue growth. Still, can Skyworks keep running ever higher?
The Federal Reserve Bank of Dallas has released its Manufacturing Outlook report for the month of March, the first negative reading on Texas manufacturing in nearly two years.
The National Association of Realtors (NAR) on Monday morning released its data on pending sales of existing homes for February.
Since late February when First Solar and SunPower announced their intention to create a joint venture yieldco, First Solar's shares are up about 21%.
The independent research firm Argus has decided to add Delta Air to its coverage universe with a relatively positive outlook.
Catamaran, a provider of pharmacy benefit management services and technology solutions, announced Monday morning that it has agreed to merge with OptumRx.
A new research report from the analysts at Merrill Lynch includes some timely additions to the firm's SMID-Cap Alpha list.
Merrill Lynch has maintained a very positive view on Micron Technology, despite slightly lower estimates, while Wells Fargo remains very cautious.